Abstract
Dyskeratosis congenita has been found to be associated with abnormal immune function. In this study we report a patient with this association. He developed Pneumocystis carinii interstitial pneumonia, and impaired cell mediated immunity was confirmed by the presence of depressed lymphoproliferative responses to in vitro stimulation with mitogen. Enumeration of T cell subsets showed a severely depressed CD4:CD8 ratio (0.38), which is the likely cause for impaired cell mediated immunity. The T cell activation pathway appeared intact, as his T lymphocytes were able to express activation markers (CD25 and HLA-DR) after mitogen stimulation.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bernstein L. J., Ochs H. D., Wedgwood R. J., Rubinstein A. Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr. 1985 Sep;107(3):352–357. doi: 10.1016/s0022-3476(85)80505-9. [DOI] [PubMed] [Google Scholar]
- Borrone C., Dagna Bricarelli F., Astrice C., Moscatelli P. Congenital dyskeratosis and immunological defect. Boll Ist Sieroter Milan. 1974;53(1):suppl–suppl:265. [PubMed] [Google Scholar]
- Connor J. M., Gatherer D., Gray F. C., Pirrit L. A., Affara N. A. Assignment of the gene for dyskeratosis congenita to Xq28. Hum Genet. 1986 Apr;72(4):348–351. doi: 10.1007/BF00290963. [DOI] [PubMed] [Google Scholar]
- DeBauche D. M., Pai G. S., Stanley W. S. Enhanced G2 chromatid radiosensitivity in dyskeratosis congenita fibroblasts. Am J Hum Genet. 1990 Feb;46(2):350–357. [PMC free article] [PubMed] [Google Scholar]
- Doi S., Saiki O., Tanaka T., Ha-Kawa K., Igarashi T., Fujita T., Taniguchi T., Kishimoto S. Cellular and genetic analyses of IL-2 production and IL-2 receptor expression in a patient with familial T-cell-dominant immunodeficiency. Clin Immunol Immunopathol. 1988 Jan;46(1):24–36. doi: 10.1016/0090-1229(88)90003-7. [DOI] [PubMed] [Google Scholar]
- Gutman A., Frumkin A., Adam A., Bloch-Shtacher N., Rozenszajn L. A. X-linked dyskeratosis congenita with pancytopenia. Arch Dermatol. 1978 Nov;114(11):1667–1671. [PubMed] [Google Scholar]
- Lee B. W., Yap H. K., Wong H. B., Giam Y. C. Two cases of dyskeratosis congenita presenting with aplastic anemia. J Singapore Paediatr Soc. 1982;24(3-4):156–158. [PubMed] [Google Scholar]
- Ortega J. A., Swanson V. L., Landing B. H., Hammond G. D. Congenital dyskeratosis. Zinsser-Engman-Cole syndrome with thymic dysplasia and aplastic anemia. Am J Dis Child. 1972 Nov;124(5):701–704. doi: 10.1001/archpedi.1972.02110170079012. [DOI] [PubMed] [Google Scholar]
- Primary immunodeficiency diseases. Report of a World Health Organization scientific group. Clin Immunol Immunopathol. 1986 Jul;40(1):166–196. [PubMed] [Google Scholar]
- Puck J. M., Nussbaum R. L., Smead D. L., Conley M. E. X-linked severe combined immunodeficiency: localization within the region Xq13.1-q21.1 by linkage and deletion analysis. Am J Hum Genet. 1989 May;44(5):724–730. [PMC free article] [PubMed] [Google Scholar]
- Sirinavin C., Trowbridge A. A. Dyskeratosis congenita: clinical features and genetic aspects. Report of a family and review of the literature. J Med Genet. 1975 Dec;12(4):339–354. doi: 10.1136/jmg.12.4.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spreitzer R. J., Goldschmidt-Clermont M., Rahire M., Rochaix J. D. Nonsense mutations in the Chlamydomonas chloroplast gene that codes for the large subunit of ribulosebisphosphate carboxylase/oxygenase. Proc Natl Acad Sci U S A. 1985 Aug;82(16):5460–5464. doi: 10.1073/pnas.82.16.5460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steier W., Van Voolen G. A., Selmanowitz V. J. Dyskeratosis congenita: relationship to Fanconi's anemia. Blood. 1972 Apr;39(4):510–521. [PubMed] [Google Scholar]
- Tchou P. K., Kohn T. Dyskeratosis congenita: an autosomal dominant disorder. J Am Acad Dermatol. 1982 Jun;6(6):1034–1039. doi: 10.1016/s0190-9622(82)80100-x. [DOI] [PubMed] [Google Scholar]